Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
ITT price target lowered to $100 from $110 at DA Davidson » 08:45
06/21/22
06/21
08:45
06/21/22
08:45
ITT

ITT

$64.30 /

-1.345 (-2.05%)

DA Davidson analyst Matt…

DA Davidson analyst Matt Summerville lowered the firm's price target on ITT to $100 from $110 to reflect the recent multiple compression in the market overall as well as the industrial tech space but keeps a Buy rating on the shares after meeting with its executive team last week. The discussions have given him a more thorough grasp of the company's core strengths and opportunities, along with some "incremental learnings" about key customer wins and strengthening tailwinds, the analyst tells investors in a research note.

ShowHide Related Items >><<
ITT ITT
$64.30 /

-1.345 (-2.05%)

ITT ITT
$64.30 /

-1.345 (-2.05%)

06/17/22 Baird
ITT remains a top idea following analyst day, says Baird
06/13/22 Cowen
ITT price target lowered to $92 from $105 at Cowen
05/04/22 Baird
ITT price target lowered to $84 from $90 at Baird
05/04/22 KeyBanc
ITT price target lowered to $100 from $113 at KeyBanc
ITT ITT
$64.30 /

-1.345 (-2.05%)

ITT ITT
$64.30 /

-1.345 (-2.05%)

Recommendations
ITT remains a top idea following analyst day, says Baird » 07:12
06/17/22
06/17
07:12
06/17/22
07:12
ITT

ITT

$65.66 /

-2.691 (-3.94%)

Baird analyst Michael…

Baird analyst Michael Halloran said ITT hosted its first analyst day since 2011 in which management showcased growth drivers across segments, products, and/markets including updates on cyclical and secular trends, reiterated the commitment to M&A, highlighted its best-in-class execution, and provided a long-term financial framework. The analyst noted ITT's balance sheet is an underappreciated lever which is robust enough to manage organic investments, M&A, dividends, and share repurchases simultaneously. Halloran reiterated his Outperform rating and $84 price target on ITT shares.

ShowHide Related Items >><<
ITT ITT
$65.66 /

-2.691 (-3.94%)

ITT ITT
$65.66 /

-2.691 (-3.94%)

06/13/22 Cowen
ITT price target lowered to $92 from $105 at Cowen
05/04/22 Baird
ITT price target lowered to $84 from $90 at Baird
05/04/22 KeyBanc
ITT price target lowered to $100 from $113 at KeyBanc
04/18/22 Stifel
ITT price target lowered to $91 from $107 at Stifel
ITT ITT
$65.66 /

-2.691 (-3.94%)

ITT ITT
$65.66 /

-2.691 (-3.94%)

On The Fly
Fly Intel: Pre-market Movers » 08:57
06/16/22
06/16
08:57
06/16/22
08:57
TWTR

Twitter

$38.00 /

+0.71 (+1.90%)

, CMRA

Comera Life Sciences

$3.69 /

+1.015 (+37.94%)

, SIDU

Sidus Space

$4.66 /

+3.23 (+225.87%)

, CMCI

CMC Industries

/

+

, ITT

ITT

$68.30 /

+0.375 (+0.55%)

, REV

Revlon

$2.25 /

+0.39 (+20.97%)

, WBD

Warner Bros. Discovery

$14.85 /

+0.875 (+6.26%)

, ABT

Abbott

$104.74 /

+1.74 (+1.69%)

, ACIU

AC Immune

$2.86 /

-0.28 (-8.92%)

, TSLA

Tesla

$698.85 /

+35.86 (+5.41%)

, EBIX

Ebix

$23.38 /

+0.34 (+1.48%)

Check out this morning's…

ShowHide Related Items >><<
WBD Warner Bros. Discovery
$14.85 /

+0.875 (+6.26%)

TWTR Twitter
$38.00 /

+0.71 (+1.90%)

TSLA Tesla
$698.85 /

+35.86 (+5.41%)

SIDU Sidus Space
$4.66 /

+3.23 (+225.87%)

REV Revlon
$2.25 /

+0.39 (+20.97%)

ITT ITT
$68.30 /

+0.375 (+0.55%)

EBIX Ebix
$23.38 /

+0.34 (+1.48%)

CMRA Comera Life Sciences
$3.69 /

+1.015 (+37.94%)

ACIU AC Immune
$2.86 /

-0.28 (-8.92%)

ABT Abbott
$104.74 /

+1.74 (+1.69%)

TWTR Twitter
$38.00 /

+0.71 (+1.90%)

06/06/22 Gordon Haskett
Ira Sohn conference may bring news on FTX and Robinhood, says Gordon Haskett
06/02/22 Piper Sandler
Twitter price target raised to $54.,20 from $51.50 at Piper Sandler
05/24/22 Jefferies
Twitter price target lowered to $40 from $48 at Jefferies
05/24/22 Wedbush
More fireworks expected heading into Twitter shareholder meeting, says Wedbush
CMRA Comera Life Sciences
$3.69 /

+1.015 (+37.94%)

SIDU Sidus Space
$4.66 /

+3.23 (+225.87%)

CMCI CMC Industries
/

+

ITT ITT
$68.30 /

+0.375 (+0.55%)

06/13/22 Cowen
ITT price target lowered to $92 from $105 at Cowen
05/04/22 Baird
ITT price target lowered to $84 from $90 at Baird
05/04/22 KeyBanc
ITT price target lowered to $100 from $113 at KeyBanc
04/18/22 Stifel
ITT price target lowered to $91 from $107 at Stifel
REV Revlon
$2.25 /

+0.39 (+20.97%)

WBD Warner Bros. Discovery
$14.85 /

+0.875 (+6.26%)

06/16/22 JPMorgan
Warner Bros. Discovery reinstated with a Neutral at JPMorgan
06/02/22 Wolfe Research
Warner Bros. Discovery price target lowered to $20 from $30 at Wolfe Research
06/02/22 Wolfe Research
Paramount assumed at Underperform from Outperform at Wolfe Research
05/12/22 Cowen
Warner Bros. Discovery upgraded on management strategy at Cowen
ABT Abbott
$104.74 /

+1.74 (+1.69%)

06/01/22 Lake Street
Abbott approval for Libre 3 'a huge positive' for Tandem, says Lake Street
05/31/22 Piper Sandler
Abbott approval bodes well for DexCom, Tandem, says Piper Sandler
05/31/22 Stifel
DexCom M&A response should put an end to recent dislocation, says Stifel
05/31/22 Wells Fargo
Wells Fargo glad DexCom, Insulet merger is not happening
ACIU AC Immune
$2.86 /

-0.28 (-8.92%)

02/15/22 H.C. Wainwright
AC Immune's ACI-35.030 data 'encouraging for platform,' says H.C. Wainwright
08/31/21 H.C. Wainwright
Cognitive results for AC's semorinemab pushes Tau 'to the fore,' says Wainwright
08/31/21 SVB Securities
AC Immune LAURIET data provides some initial validation, says SVB Leerink
TSLA Tesla
$698.85 /

+35.86 (+5.41%)

06/15/22 Mizuho
Mizuho likes three electric vehicle stocks into second half rebound
06/14/22 Morgan Stanley
Morgan Stanley says 'very prudent' to shift some Tesla production to Q3 from Q2
06/13/22 RBC Capital
RBC Capital upgrades Tesla to Outperform on near-term improvement, positioning
06/13/22 RBC Capital
Tesla upgraded to Outperform from Sector Perform at RBC Capital
EBIX Ebix
$23.38 /

+0.34 (+1.48%)

03/10/22 Craig-Hallum
Ebix price target raised to $150 from $100 at Craig-Hallum
03/09/22 Craig-Hallum
Ebix price target raised to $100 from $75 at Craig-Hallum
WBD Warner Bros. Discovery
$14.85 /

+0.875 (+6.26%)

TWTR Twitter
$38.00 /

+0.71 (+1.90%)

TSLA Tesla
$698.85 /

+35.86 (+5.41%)

SIDU Sidus Space
$4.66 /

+3.23 (+225.87%)

REV Revlon
$2.25 /

+0.39 (+20.97%)

ITT ITT
$68.30 /

+0.375 (+0.55%)

EBIX Ebix
$23.38 /

+0.34 (+1.48%)

ACIU AC Immune
$2.86 /

-0.28 (-8.92%)

ABT Abbott
$104.74 /

+1.74 (+1.69%)

  • 15
    Dec
WBD Warner Bros. Discovery
$14.85 /

+0.875 (+6.26%)

TWTR Twitter
$38.00 /

+0.71 (+1.90%)

TSLA Tesla
$698.85 /

+35.86 (+5.41%)

REV Revlon
$2.25 /

+0.39 (+20.97%)

EBIX Ebix
$23.38 /

+0.34 (+1.48%)

ABT Abbott
$104.74 /

+1.74 (+1.69%)

WBD Warner Bros. Discovery
$14.85 /

+0.875 (+6.26%)

TWTR Twitter
$38.00 /

+0.71 (+1.90%)

SIDU Sidus Space
$4.66 /

+3.23 (+225.87%)

REV Revlon
$2.25 /

+0.39 (+20.97%)

EBIX Ebix
$23.38 /

+0.34 (+1.48%)

CMCI CMC Industries
/

+

ABT Abbott
$104.74 /

+1.74 (+1.69%)

WBD Warner Bros. Discovery
$14.85 /

+0.875 (+6.26%)

TWTR Twitter
$38.00 /

+0.71 (+1.90%)

TSLA Tesla
$698.85 /

+35.86 (+5.41%)

REV Revlon
$2.25 /

+0.39 (+20.97%)

EBIX Ebix
$23.38 /

+0.34 (+1.48%)

ABT Abbott
$104.74 /

+1.74 (+1.69%)

Earnings
ITT sees long-term adjusted EPS growth of 10%, revenue growth of 5%-7% » 06:33
06/16/22
06/16
06:33
06/16/22
06:33
ITT

ITT

$68.30 /

+0.375 (+0.55%)

ITT will host its…

ITT will host its investor conference and deliver a series of presentations focusing on its strategic priorities, innovative technologies, long-term vision, and financial framework at 1 PM ET on June 16th. In connection with the conference, ITT also announced long-term financial targets, which comprise 5-7% revenue growth, 20% adjusted segment operating margin, over 10% adjusted EPS growth, and a free cash flow margin range of 11%-13%, all based on actual results for the year 2021. The company will also host an interactive technology demonstration at the event, which will take place at Current at Chelsea Piers in New York, NY.

ShowHide Related Items >><<
ITT ITT
$68.30 /

+0.375 (+0.55%)

ITT ITT
$68.30 /

+0.375 (+0.55%)

06/13/22 Cowen
ITT price target lowered to $92 from $105 at Cowen
05/04/22 Baird
ITT price target lowered to $84 from $90 at Baird
05/04/22 KeyBanc
ITT price target lowered to $100 from $113 at KeyBanc
04/18/22 Stifel
ITT price target lowered to $91 from $107 at Stifel
ITT ITT
$68.30 /

+0.375 (+0.55%)

Hot Stocks
ITT acquires manufacturing capacity with investment in CRP » 07:05
06/14/22
06/14
07:05
06/14/22
07:05
ITT

ITT

$68.19 /

-2.5 (-3.54%)

ITT announced its…

ITT announced its investment in CRP Technology and CRP USA . CRP is an industry leader in developing and manufacturing reinforced composite materials for 3D printing for the aerospace, defense, premium automotive, and motorsports industries. The company's Windform high-performance materials enable engineers to develop complex, customized designs while providing lightweight and exceptionally durable products. With this investment, ITT owns 46% of CRP Technology and 33% of CRP USA. "CRP is a smart investment for ITT. With almost three decades of leadership and innovation in additive manufacturing, CRP enables ITT to expand its position in material science and gain hands-on experience with additive manufacturing as the industries we serve continue to transform," said Luca Savi, Chief Executive Officer and President of ITT. "We are proud to partner with CRP as they continue to grow and deliver industry-changing innovations. Together, ITT and CRP can bring to market new products that deliver sustainable, lightweight, durable solutions for our customers."

ShowHide Related Items >><<
ITT ITT
$68.19 /

-2.5 (-3.54%)

ITT ITT
$68.19 /

-2.5 (-3.54%)

06/13/22 Cowen
ITT price target lowered to $92 from $105 at Cowen
05/04/22 Baird
ITT price target lowered to $84 from $90 at Baird
05/04/22 KeyBanc
ITT price target lowered to $100 from $113 at KeyBanc
04/18/22 Stifel
ITT price target lowered to $91 from $107 at Stifel
ITT ITT
$68.19 /

-2.5 (-3.54%)

Recommendations
ITT price target lowered to $92 from $105 at Cowen » 07:40
06/13/22
06/13
07:40
06/13/22
07:40
ITT

ITT

$70.45 /

-3.76 (-5.07%)

Cowen analyst Joseph…

Cowen analyst Joseph Giordano lowered the firm's price target on ITT to $92 from $105 and keeps an Outperform rating on the shares. The analyst believes the company is poised to capitalize on strength in energy/chemical markets and recoveries in commercial aerospace and automotive while its respected leadership team begins deploying the now asbestos-free balance sheet after many years of minimal activity.

ShowHide Related Items >><<
ITT ITT
$70.45 /

-3.76 (-5.07%)

ITT ITT
$70.45 /

-3.76 (-5.07%)

05/04/22 Baird
ITT price target lowered to $84 from $90 at Baird
05/04/22 KeyBanc
ITT price target lowered to $100 from $113 at KeyBanc
04/18/22 Stifel
ITT price target lowered to $91 from $107 at Stifel
04/08/22 UBS
ITT upgraded to Buy from Neutral at UBS
ITT ITT
$70.45 /

-3.76 (-5.07%)

Over a month ago
Recommendations
ITT price target lowered to $84 from $90 at Baird » 06:52
05/04/22
05/04
06:52
05/04/22
06:52
ITT

ITT

$72.92 /

+1.35 (+1.89%)

Baird analyst Michael…

Baird analyst Michael Halloran lowered the firm's price target on ITT to $84 from $90 and keeps an Outperform rating on the shares. The analyst suspects demand/volumes prove resilient as the company's markets appear closer to bottoms creating an attractive setup into 2023 and a favorable risk/reward in his view. He continues to believe organic earnings power is underestimated, and capital deployment serves as an upside lever.

ShowHide Related Items >><<
ITT ITT
$72.92 /

+1.35 (+1.89%)

ITT ITT
$72.92 /

+1.35 (+1.89%)

05/04/22 KeyBanc
ITT price target lowered to $100 from $113 at KeyBanc
04/18/22 Stifel
ITT price target lowered to $91 from $107 at Stifel
04/08/22 UBS
ITT upgraded to Buy from Neutral at UBS
03/28/22 Oppenheimer
ITT downgraded to Perform from Outperform at Oppenheimer
ITT ITT
$72.92 /

+1.35 (+1.89%)

Recommendations
ITT price target lowered to $100 from $113 at KeyBanc » 06:38
05/04/22
05/04
06:38
05/04/22
06:38
ITT

ITT

$72.92 /

+1.35 (+1.89%)

KeyBanc analyst Jeffrey…

KeyBanc analyst Jeffrey Hammond lowered the firm's price target on ITT to $100 from $113 and keeps an Overweight rating on the shares following Q1 earnings and conference call. The analyst finds the recent pullback in shares as a compelling entry point, with earnings de-risked and near-term headwinds well-managed. He sees plenty of cycle momentum across all three business, and expects further capital allocation catalysts.

ShowHide Related Items >><<
ITT ITT
$72.92 /

+1.35 (+1.89%)

ITT ITT
$72.92 /

+1.35 (+1.89%)

04/18/22 Stifel
ITT price target lowered to $91 from $107 at Stifel
04/08/22 UBS
ITT upgraded to Buy from Neutral at UBS
03/28/22 Oppenheimer
ITT downgraded to Perform from Outperform at Oppenheimer
02/11/22 Citi
ITT price target lowered to $112 from $124 at Citi
ITT ITT
$72.92 /

+1.35 (+1.89%)

Earnings
ITT backs FY22 adjusted EPS view $4.30-$4.70, consensus $4.46 » 06:37
05/03/22
05/03
06:37
05/03/22
06:37
ITT

ITT

$71.57 /

+1.36 (+1.94%)

The company stated,…

The company stated, "We continue to expect revenue growth of 7% to 9%, or up 9% to 11% on an organic basis; segment operating margin of 17.5% to 18.4%; and adjusted segment operating margin of 17.6% to 18.5%, up 40 to 130 bps. We now expect earnings per share of $4.07 to $4.50, with no change to adjusted earnings per share of $4.30 to $4.70 per share, up 6% to 16%. Free cash flow is now expected to be in a range of $250 million to $300 million, representing free cash flow margin of approximately 8% to 10% for the full year. The company's 2022 guidance assumes continued disruptions in the global supply chain stemming from labor shortages, supplier delays, and raw material inflation, which we anticipate will persist through at least the first half of 2022. The guidance also assumes a significant reduction in sales in Russia stemming from the conflict in Ukraine, which we currently estimate will impact revenue by approximately $60 to $85 million for the full year. The guidance does not include the potential impact, if any, of a prolonged shutdown in China due to the reemergence of COVID-19."

ShowHide Related Items >><<
ITT ITT
$71.57 /

+1.36 (+1.94%)

ITT ITT
$71.57 /

+1.36 (+1.94%)

04/18/22 Stifel
ITT price target lowered to $91 from $107 at Stifel
04/08/22 UBS
ITT upgraded to Buy from Neutral at UBS
03/28/22 Oppenheimer
ITT downgraded to Perform from Outperform at Oppenheimer
02/11/22 Citi
ITT price target lowered to $112 from $124 at Citi
ITT ITT
$71.57 /

+1.36 (+1.94%)

Earnings
ITT reports Q1 adjusted EPS 97c, consensus 97c » 06:36
05/03/22
05/03
06:36
05/03/22
06:36
ITT

ITT

$71.57 /

+1.36 (+1.94%)

Reports Q1 revenue…

Reports Q1 revenue $762.2M, consensus $695.27M.

ShowHide Related Items >><<
ITT ITT
$71.57 /

+1.36 (+1.94%)

ITT ITT
$71.57 /

+1.36 (+1.94%)

04/18/22 Stifel
ITT price target lowered to $91 from $107 at Stifel
04/08/22 UBS
ITT upgraded to Buy from Neutral at UBS
03/28/22 Oppenheimer
ITT downgraded to Perform from Outperform at Oppenheimer
02/11/22 Citi
ITT price target lowered to $112 from $124 at Citi
ITT ITT
$71.57 /

+1.36 (+1.94%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.